Author: Noah de Jong

  • New study results published by The Lancet Digital Health

    New study results published by The Lancet Digital Health

    March 5, 2024 – Last night, the results of the first large-scale study involving a bi-hormonal fully closed-loop system with individuals with type 1 diabetes were published, presenting the outcomes of the Inreda AP®. Over 70 individuals used the Inreda AP® for a period of 1 year. The results have been analysed by researchers and…

  • MDR CE certificate for Inreda AP®

    MDR CE certificate for Inreda AP®

    On the 16th of December 2023, Inreda Diabetic BV received a CE certificate for the Inreda AP® as evidence that it complies with the new European regulation for medical devices, which is the MDR (Medical Device Regulation). We are very proud of this achievement! From the old to the new legislation The Inreda AP® had…

  • 100.000 treatment days!

    100.000 treatment days!

    The holiday season is right around the corner and we, on behalf of Inreda Diabetic, wish everyone happy holidays! For us, the holidays are all about looking back on milestones of the past year. We achieved another very nice milestone at the end of the year, which we consider a gift. Together, the Inreda AP®…

  • Attention to diabetes during World Diabetes Day

    Attention to diabetes during World Diabetes Day

    Diabetes, one of the most underestimated diseases in the world. In the Netherlands, there are about 1.2 million people with diabetes, of whom about 10% are affected by type 1. Type 1 diabetes, a second-day job without ever having a break. Pricking, measuring, eating… all day long. Thoughts like: can I exercise? Can I eat…

  • The first results of a long-term study will be presented at EASD 2023

    The first results of a long-term study will be presented at EASD 2023

    This coming October, Inreda® Diabetic will be present at EASD 2023 in Hamburg. At this exhibition, we will make our debut with our own stand and will represent our company to spread word about the Inreda AP®. Thereby, the results of a first long-term study with the Inreda AP® will be presented! But, what is…